<DOC>
	<DOCNO>NCT00160680</DOCNO>
	<brief_summary>Comparison clinical efficacy safety levocetirizine PER continuous versus demand , measure evolution individual symptom score 6 month .</brief_summary>
	<brief_title>ATAREAL ( Antihistamine Treatment Allergic Rhinitis Real Life )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Clinical history PER require treatment know least since 2 year . Positive skin prick test ( wheal &gt; 3 mm large diluent control ) RAST ( ≥3.5 IU/ml ) HDM Parietaria ( less 1 year ) . Minimum mean T4SS 6 baseline period . Subjects currently treat specific parietaria pollen immunotherapy Subjects suffer nonallergic asthma Chronic use inhale steroid and/or long act β2 agonist ; and/or corticosteroid dependent asthma ( severe asthma ) Atopic dermatitis urticaria require antihistamine treatment administration oral topical corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Persistent Allergic Rhinitis , HDM , Parietaria , sneeze , rhinorrhea , ocular pruritus , Rhinasthma , inflammatory cell , ICAM-1 , ATAREAL , Xyzal , Levocetirizine</keyword>
</DOC>